Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards

Life Health > Health Insurance > Life Insurance Strategies

China’s H10N8 bird flu has deadly cousins

Your article was successfully shared with the contacts you provided.

(Bloomberg) — The new bird flu that’s infected two people in China, killing one, was spawned by the same pathogen that produced two other deadly flu strains, a study found.

The new H10N8 strain, which hasn’t previously been reported in humans, contains six out of eight genes from the H9N2 virus that also provided the genetic foundation for the H5N1 virus that’s killed 386 people since 2003, and the H7N9 strain that led to at least 70 fatalities, Chinese researchers wrote in The Lancet medical journal today.

The new virus killed a 73-year-old woman in the southeastern city of Nanchang in December, and a second case was identified last week in a 55-year-old person in the same province. H10N8 contains a mutation that helps it adapt to mammals, and may enable the virus to become more infectious, the researchers, led by Yuelong Shu at the Chinese Center for Disease Control and Prevention, wrote.

“The pandemic potential of this novel virus should not be underestimated,” Shu and colleagues wrote. “Although we cannot predict whether an H10N8 epidemic will occur, our findings suggest that the virus is a potential threat to people.”

The dead woman had visited a live poultry market a few days before becoming unwell, though the virus wasn’t found in samples collected later from the market and the source of infection remains unknown, the researchers said.

The new virus was sensitive to drugs such as Roche Holding AG’s Tamiflu.

–Editors: Robert Valpuesta, Thomas Mulier

See also:


© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.